Paracetamol Infusion Market Overview, Share, Growth | Global Forecast Report 2028

According to Precision Business Insights (PBI) latest report, the global paracetamol infusion market is valued at USD 699.1 million in 2021 and growing at a significant CAGR of 3.86% over 2022-2028. The marketplace is booming due to the rising burden of symptomatic conditions and the usage of OTC medications. The success of the paracetamol infusion market is due to a number of factors. Migraine, for example, is the world's third most common ailment, pertaining to the Migraine Trust. It's also a potent antipyretic that helps to lower fevers. The growing frequency of chronic illnesses and conditions requiring pain management drives the demand for paracetamol infusions. The enormous number of generics available and fierce competition and side effects of paracetamol may limit the market growth.

View the detailed report description here - https://precisionbusinessinsights.com/market-reports/paracetamol-infusion-market/

Fever and Pain Segment Dominates the Paracetamol Infusion Market:
Based on application, the fever and pain segment holds the largest market share in 2021. Consumers depend on OTC medicines as a first response to get relief from fever and pain. The sale of paracetamol medications for fever and pain has surged, particularly in large growing markets like India and China, due to the simplicity of procurement. Additionally, one of the primary drivers for market expansion is the rising number of people suffering from colds and coughs, as well as increased awareness.

North America Leads Paracetamol Infusion Market:
North America's paracetamol infusion market share is projected to record commendable growth through 2028. During the projected period, market growth in the United States is expected to be strong. According to the Migraine Research Foundation, more than 4 million people in the United States suffer from chronic daily migraine, with at least 15 migraine days per month. Furthermore, favourable government efforts and an increase in the number of research partnerships are projected to propel the industry forward. Due to supporting healthcare regulations, higher per-tablet costs, a large number of patients, and an established healthcare sector, the United States holds the largest share in this region. The Asia Pacific paracetamol infusion market is expanding at a rapid pace, owing to an ageing population, decreased medicine costs, and immediate pain and fever relief.

Strategic New Product Launches, Mergers, Acquisitions and Agreements are the key strategies adopted by market players:
Global paracetamol infusion market further reveals that the key players increasingly adopting strategies such as launch of newer products, product launches, and long-term alliance to improve market revenue share and gaining significant geographic presence across the region. For instance, In January 2020, Novartis AG has completed the acquisition of The Medicines Company through the consummation of a merger of its indirect wholly-owned subsidiary, Medusa Merger Corporation with and into the Company, with the Company surviving the merger, without a vote of the Company's stockholders in accordance with Section 251(h) of the Delaware General Corporation Law. In April 2021, Amgen has successfully completed its previously announced tender offer to purchase all outstanding shares of common stock of Five Prime Therapeutics a clinical-stage biotechnology company for $38.00 per share in cash. The aggregate consideration to be paid by Amgen to complete the tender offer and the subsequent merger is approximately $1.9 billion without giving effect to related transaction fees and expenses.

Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=37925

The paracetamol infusion market is segmented based on application and geography.
Based on the application, the market is segmented into the following:
• Fever
• Pain
• Patent Ductus Arteriosus
• Others

Based on geography, the market is segmented into the following:
• North America
• Europe
• The Asia Pacific
• Latin America
• MEA

Request Methodology: https://precisionbusinessinsights.com/request-methodology?product_id=37925

Key player's profiles in the paracetamol infusion market report are Altan Pharma Limited, Unital Pharmaceuticals, Stellar- Bio Labs, Sun Pharma, Novartis, Cipla, Pfizer, Amgen, Inc, Sanofi.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 85278174

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet particular research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

This release was published on openPR.